CT3N Pilot Grants
The competition for the 2021 CT3N pilot grants is now closed.
Congratulations to the awardees of the 2021 pilot grants, Oscar A. Marcos-Contreras for “Erythrocyte Targeting of Pro-Hemostatic Drugs for the Treatment of Hemophilia”, and Vijay G. Bhoj for “Development of an Immunoreceptor-Engineered Extracellular Vesicle Platform to Enhance T cell Activity Against Solid Tumors”!
The CT3N invites PENN and CHOP researchers to submit competitive proposals for Pilot Grants by August 16, 2021. The goal of these Pilot Grants is to support early‐stage experimental preclinical studies in targeted therapeutics and thus assist investigators in obtaining key data to seek extramural funding. Proposals will be evaluated based on their relevance to CT3N’s areas of interest, the interdisciplinary and collaborative character (including use of PENN and CHOP core facilities, such as for instance the Chemical and Nanoparticle Synthesis Core), and innovation and translational potential. Two $40,000 grants will be awarded for one year, starting October 15, 2021.
Please refer to the ITMAT Funding Opportunities page with detailed grant instructions and templates: Link